
Microbiome Therapeutics
Microbiome modulators for prediabetes and diabetes treatment.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
investor | €0.0 | round | |
$1.0m | Series B | ||
Total Funding | 000k |
Related Content
MicroBiome Therapeutics, LLC, founded in 2009 by Dale Pfost and John Elstrott, is a biotechnology company focused on developing microbiome modulators to treat conditions like prediabetes and diabetes. The company, which has operated under the name NuMe Health, develops products designed to modify the bacteria populations and their environment in the gastrointestinal tract to improve health.
The company was co-founded by CEO Dale Pfost, a five-time biotechnology entrepreneur, and Chairman John Elstrott, the former chairman of Whole Foods Market. Pfost has a background in physics and has launched several successful biotech companies, while Elstrott brings experience from the natural foods industry and academia. Their combined expertise guided the company's focus on the intersection of diet, health, and the microbiome. The company's chief scientific officer, Mark Heiman, is a former researcher from Eli Lilly who specializes in neuroendocrinology and obesity.
MicroBiome Therapeutics' lead product is NM504, a microbiome modulator aimed at helping diabetic individuals manage blood glucose levels and body weight. In 2018, the company launched BiomeBliss™, a prebiotic dietary supplement derived from natural ingredients like blueberries, agave, and oats. Clinical studies have shown that BiomeBliss can help control hunger, promote regularity, and support healthy blood sugar levels. The company's business model centers on creating evidence-based, scientifically formulated products for the consumer health and wellness market, making them available directly to consumers through online channels. As of late 2017, the company had raised over $5.2 million in funding through multiple rounds to support its research and product development.
Keywords: microbiome modulator, prediabetes, diabetes treatment, gut health, prebiotic supplement, gastrointestinal science, metabolic health, blood glucose management, dietary supplements, biotechnology, consumer wellness, natural ingredients, clinical nutrition, obesity research, microbial therapy